kanamycin A

Metabolite details

Identifier

SBUJHOSQTJFQJX-NOAMYHISSA-N

InChI Key

SBUJHOSQTJFQJX-NOAMYHISSA-N

IUPAC name

(1S,2R,3R,4S,6R)-4,6-diamino-3-(6-amino-6-deoxy-α-D-glucopyranosyloxy)-2-hydroxycyclohexyl 3-amino-3-deoxy-α-D-glucopyranoside

Preferred name

kanamycin A

INN name

—

Synonym

O-3-amino-3-deoxy-α-D-glucopyranosyl-(1→6)-O-(6-amino-6-deoxy-α-D-glucopyranosyl-(1→4))-2-deoxy-D-streptamine

ChEBI

CHEBI:17630

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Effect of L-carnitine administration on lipid and metabolite content in sheep infraspinatus muscle after tendon release
• Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
• Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
• Transcriptomics and metabolomics of engineered Synechococcus elongatus during photomixotrophic growth
• Integrated Metabolomics and Transcriptomics Analyses Reveal Anthocyanin and Carotenoid Biosynthesis Involved in Color Development in Willow Bark

Observed in differential profiles

• Control_16.6_months_vs_Treatment_16.6_months
• G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
• G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
• Wild_Type_vs_YQ2-gal
• Purple_vs_Green